Kurin Revenue and Competitors

Location

N/A

Total Funding

Medical

Industry

Employee Data

  • Kurin has 92 Employees.(i)
  • Kurin grew their employee count by -8% last year.

Kurin's People

NameTitleEmail/Phone
1
Founder and EVP Marketing and Business DevelopmentReveal Email/Phone
2
VP Sales, Eastern RegionReveal Email/Phone
3
Regional Director, Clinical OperationsReveal Email/Phone
4
Clinical Outcomes DirectorReveal Email/Phone
5
Senior Territory ManagerReveal Email/Phone
6
Territory ManagerReveal Email/Phone
7
Executive Territory ManagerReveal Email/Phone
8
EngineeringReveal Email/Phone
9
Territory Sales ManagerReveal Email/Phone
10
Founder/CEO/Chairman Reveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A8-27%N/AN/A
#2
$1.7M336%N/AN/A
#3
N/A1645%N/AN/A
#4
$1.7M40%$1.7MN/A
#5
$7.5M240%N/AN/A
#6
N/A60%N/AN/A
#7
N/A2-92%N/AN/A
#8
N/A70%N/AN/A
#9
N/A8922%N/AN/A
#10
N/A3314%N/AN/A
Add Company

What Is Kurin?

Kurin® is a privately held, certified minority owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies. Building on the successful invention, clinical adoption, and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience in medical device engineering, marketing, sales and service, to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we have seen the Kurin Lock® with Flash Technology quickly gain caregiver acceptance, sideline skin contaminants during blood culture collection, and become the blood culture collection standard of care in hospitals. Curos™ is a registered trademark of 3M Corporation.

keywords:N/A

N/A

Total Funding

92

Number of Employees

N/A

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.4M92-3%N/A
#2
$12.9M920%$23.1M
#3
$23.1M920%N/A
#4
$19.3M92-16%N/A
#5
$16.6M9235%N/A